1. Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF.
- Author
-
Nako H, Kataoka K, Koibuchi N, Dong YF, Toyama K, Yamamoto E, Yasuda O, Ichijo H, Ogawa H, and Kim-Mitsuyama S
- Subjects
- Animals, Antihypertensive Agents pharmacology, Apoptosis drug effects, Biphenyl Compounds pharmacology, Blood Pressure physiology, Blotting, Western, Capillaries drug effects, Cells, Cultured, Cyclic N-Oxides pharmacology, Endothelial Cells drug effects, Heart Diseases diagnostic imaging, Heart Diseases pathology, Hydralazine pharmacology, Hypertension complications, Hypertension diagnostic imaging, Hypertrophy, Left Ventricular pathology, Immunohistochemistry, Irbesartan, Myocardial Ischemia physiopathology, Oxidative Stress drug effects, Rats, Rats, Inbred Dahl, Reactive Oxygen Species metabolism, Real-Time Polymerase Chain Reaction, Spin Labels, Superoxides metabolism, Tetrazoles pharmacology, Ultrasonography, Angiotensin II toxicity, Heart Diseases chemically induced, Hypertension physiopathology, MAP Kinase Kinase Kinase 5 physiology, Vascular Endothelial Growth Factor A physiology
- Abstract
This study was undertaken to elucidate a novel mechanism underlying angiotensin II-induced cardiac injury, focusing on the role of oxidative stress and myocardial capillary density. Salt-loaded Dahl salt-sensitive hypertensive rats (DS rats), a useful model for hypertensive cardiac remodeling or heart failure, were orally given irbesartan (an AT1 receptor blocker), tempol (a superoxide dismutase mimetic) or hydralazine (a vasodilator). Irbesartan significantly ameliorated left ventricular ischemia and prevented the development of cardiac hypertrophy and fibrosis in DS rats. The benefits were associated with the attenuation of oxidative stress, normalization of myocardial capillary density and inhibition of capillary endothelial apoptosis. Moreover, DS rats with significant cardiac hypertrophy and fibrosis displayed decreased myocardial vascular endothelial growth factor (VEGF) expression and increased cardiac apoptosis signal-regulating kinase 1 (ASK1) activation. Treatment with irbesartan significantly reversed these phenotypes. Tempol treatment of DS rats mimicked all the above-mentioned effects of irbesartan, indicating the critical role of oxidative stress in cardiac injury. We also investigated the role of VEGF and ASK1 in oxidative stress-induced endothelial apoptosis by using cultured endothelial cells from wild-type and ASK1-deficient mice. Oxidative stress-induced ASK1 activation led to endothelial apoptosis, and VEGF treatment prevented oxidative stress-induced endothelial apoptosis by inhibiting ASK1 activation. We obtained the first evidence that oxidative stress-induced cardiac VEGF repression and ASK1 activation caused the enhancement of endothelial apoptosis and contributed to a decrease in myocardial capillary density. These effects resulted in angiotensin II-induced progression of cardiac injury.
- Published
- 2012
- Full Text
- View/download PDF